Universe Pharmaceuticals Inc - Class A Ordinary Shares (UPC)
6.4800
+3.3200 (105.06%)
NASDAQ· Last Trade: Aug 3rd, 9:03 PM EDT
Detailed Quote
Previous Close
3.160
Open
7.020
Bid
6.300
Ask
6.450
Day's Range
5.510 - 8.440
52 Week Range
2.000 - 17.96
Volume
28,031,447
Market Cap
23.63M
PE Ratio (TTM)
-0.8040
EPS (TTM)
-8.1
Dividend & Yield
N/A (N/A)
1 Month Average Volume
2,011,989
Chart
About Universe Pharmaceuticals Inc - Class A Ordinary Shares (UPC)
Universe Pharmaceuticals Inc is a company focused on the development, manufacturing, and distribution of high-quality pharmaceutical products, particularly in the realm of traditional Chinese medicine. The company aims to leverage advanced technologies and sustainable practices to create innovative therapeutics that address various health conditions. With a commitment to research and development, Universe Pharmaceuticals also emphasizes the importance of quality control and regulatory compliance in its operations, ensuring that its products meet rigorous industry standards. Through these efforts, the firm seeks to enhance healthcare outcomes and provide accessible solutions for patients globally. Read More
Gainers Universe Pharmaceuticals (NASDAQ:UPC) shares increased by 108.5% to $6.59 during Monday's regular session. The market value of their outstanding shares is at $2.0 million. SL Science Holding (NASDAQ:SLBT)
Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock increased by 121.2% to $6.99 during Monday's pre-market session. The market value of their outstanding shares is at $2.0 million. Supernus Pharmaceuticals
Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock increased by 91.1% to $6.04 during Friday's after-market session. The company's market cap stands at $2.2 million. BGM Group (NASDAQ:BGM) stock rose 11.63%
Gainers Seer (NASDAQ:SEER) stock moved upwards by 33.3% to $2.16 during Thursday's after-market session. The market value of their outstanding shares is at $89.6 million. Universe Pharmaceuticals (NASDAQ:UPC)
Investors searching for emerging opportunities under $5 are increasingly focusing on companies operating in some of today's fastest-growing industries, including Artificial Intelligence (AI), AI Infrastructure, Data Centers, Pharmaceutical Innovation, Biotechnology, High-Performance Computing (HPC), Cloud Computing, Drug Development, and Digital Infrastructure .
Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 284.8% to $11.39 during Monday's regular session. The company's market cap stands at $1.9 million. Decoy Therapeutics (NASDAQ:DCOY) shares
Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 159.6% to $7.68 during Monday's pre-market session. The company's market cap stands at $1.9 million. Decoy Therapeutics (NASDAQ:DCOY) stock
Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 168.2% to $7.94 during Friday's after-market session. The market value of their outstanding shares is at $1.8 million. Tvardi Therapeutics
Ji'an, Jiangxi, China, June 26, 2026 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China, today announced that the Company has entered into a share purchase agreement to acquire 100% of the issued shares of Best Praise International Limited (“Best Praise”), a company that holds five patents in China with potential applications in pharmaceutical development, for a total purchase price of US$10,751,000, payable in the form of 4,376,552 Class A ordinary shares of the Company.
Ji'an, Jiangxi, China, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China, today announced that all conditions to the implementation of its dual-class share structure have been satisfied and that its dual-class share structure will become effective on the Nasdaq Capital Market on February 13, 2026.
